Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-16
DOI
10.1038/s41467-021-24562-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pan-cancer analysis of whole genomes
- (2020) NATURE
- Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution
- (2020) Michelle Chan-Seng-Yue et al. NATURE GENETICS
- CRISPR-engineered T cells in patients with refractory cancer
- (2020) Edward A. Stadtmauer et al. SCIENCE
- A metastasis map of human cancer cell lines
- (2020) Xin Jin et al. NATURE
- Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
- (2019) Gal Cafri et al. Nature Communications
- Interactive Peptide Spectral Annotator: A Versatile Web-Based Tool for Proteomic Applications
- (2019) Dain R. Brademan et al. MOLECULAR & CELLULAR PROTEOMICS
- Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function
- (2019) Kilian Schober et al. Nature Biomedical Engineering
- Direct Detection and Quantification of Neo-antigens
- (2019) Qing Wang et al. Cancer Immunology Research
- Pan-cancer whole-genome analyses of metastatic solid tumours
- (2019) Peter Priestley et al. NATURE
- The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
- (2019) Jude Canon et al. NATURE
- Cracking KRAS
- (2019) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Immunological ignorance is an enabling feature of the oligo-clonal T cell response to melanoma neoantigens
- (2019) Gerald P. Linette et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
- (2019) Jill Hallin et al. Cancer Discovery
- An in silico—in vitro Pipeline Identifying an HLA-A*02:01+ KRAS G12V+ Spliced Epitope Candidate for a Broad Tumor-Immune Response in Cancer Patients
- (2019) Michele Mishto et al. Frontiers in Immunology
- Neoantigen Dissimilarity to the Self-Proteome Predicts Immunogenicity and Response to Immune Checkpoint Blockade
- (2019) Lee P. Richman et al. Cell Systems
- A large peptidome dataset improves HLA class I epitope prediction across most of the human population
- (2019) Siranush Sarkizova et al. NATURE BIOTECHNOLOGY
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- Computational Evaluation of B-Cell Clone Sizes in Bulk Populations
- (2018) Aaron M. Rosenfeld et al. Frontiers in Immunology
- Checkpoint blockade reverses anergy in IL13Rα2 humanized scFv based CAR T cells to treat murine and canine gliomas.
- (2018) Yibo Yin et al. Molecular Therapy-Oncolytics
- Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
- (2017) Jennifer G. Abelin et al. IMMUNITY
- The Skyline ecosystem: Informatics for quantitative mass spectrometry proteomics
- (2017) Lindsay K. Pino et al. MASS SPECTROMETRY REVIEWS
- Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
- (2017) Ugur Sahin et al. NATURE
- An immunogenic personal neoantigen vaccine for patients with melanoma
- (2017) Patrick A. Ott et al. NATURE
- An atlas of B-cell clonal distribution in the human body
- (2017) Wenzhao Meng et al. NATURE BIOTECHNOLOGY
- MHC class I–associated peptides derive from selective regions of the human genome
- (2016) Hillary Pearson et al. JOURNAL OF CLINICAL INVESTIGATION
- T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
- (2016) Eric Tran et al. NEW ENGLAND JOURNAL OF MEDICINE
- Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
- (2016) Michal Bassani-Sternberg et al. Nature Communications
- pVAC-Seq: A genome-guided in silico approach to identifying tumor neoantigens
- (2016) Jasreet Hundal et al. Genome Medicine
- Automated benchmarking of peptide-MHC class I binding predictions
- (2015) Thomas Trolle et al. BIOINFORMATICS
- Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes
- (2015) Cyrille J. Cohen et al. JOURNAL OF CLINICAL INVESTIGATION
- Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation
- (2015) Michal Bassani-Sternberg et al. MOLECULAR & CELLULAR PROTEOMICS
- MiXCR: software for comprehensive adaptive immunity profiling
- (2015) Dmitriy A Bolotin et al. NATURE METHODS
- Guidelines for the automated evaluation of Elispot assays
- (2015) Sylvia Janetzki et al. Nature Protocols
- Immunogenicity of somatic mutations in human gastrointestinal cancers
- (2015) E. Tran et al. SCIENCE
- A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
- (2015) B. M. Carreno et al. SCIENCE
- TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression
- (2015) Jelle Scholtalbers et al. Genome Medicine
- VDJtools: Unifying Post-analysis of T Cell Receptor Repertoires
- (2015) Mikhail Shugay et al. PLoS Computational Biology
- Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors
- (2015) Q. J. Wang et al. Cancer Immunology Research
- Phase II Study of the GI-4000 KRAS Vaccine After Curative Therapy in Patients With Stage I-III Lung Adenocarcinoma Harboring a KRAS G12C, G12D, or G12V Mutation
- (2014) Jamie E. Chaft et al. Clinical Lung Cancer
- Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing
- (2014) Mahesh Yadav et al. NATURE
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations
- (2014) Faviel F. González-Galarza et al. NUCLEIC ACIDS RESEARCH
- The repertoire of human tumor-associated epitopes — identification and selection of antigens and their application in clinical trials
- (2013) Sebastian P Haen et al. CURRENT OPINION IN IMMUNOLOGY
- IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity
- (2013) Beatriz M. Carreno et al. JOURNAL OF CLINICAL INVESTIGATION
- Peptide-MHC class I stability is a better predictor than peptide affinity of CTL immunogenicity
- (2012) Mikkel Harndahl et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Amino-Terminal Extended Peptide Single-Chain Trimers Are Potent Synthetic Agonists for Memory Human CD8+ T Cells
- (2012) B. M. Carreno et al. JOURNAL OF IMMUNOLOGY
- Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics
- (2012) Amelia C. Peterson et al. MOLECULAR & CELLULAR PROTEOMICS
- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- (2010) Brendan MacLean et al. BIOINFORMATICS
- Real-time, high-throughput measurements of peptide–MHC-I dissociation using a scintillation proximity assay
- (2010) Mikkel Harndahl et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now